[go: up one dir, main page]

AU2003251303A1 - Pharmaceutical products and methods of manufacture - Google Patents

Pharmaceutical products and methods of manufacture

Info

Publication number
AU2003251303A1
AU2003251303A1 AU2003251303A AU2003251303A AU2003251303A1 AU 2003251303 A1 AU2003251303 A1 AU 2003251303A1 AU 2003251303 A AU2003251303 A AU 2003251303A AU 2003251303 A AU2003251303 A AU 2003251303A AU 2003251303 A1 AU2003251303 A1 AU 2003251303A1
Authority
AU
Australia
Prior art keywords
manufacture
methods
pharmaceutical products
pharmaceutical
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003251303A
Inventor
Andrew Bruce Brown
Matthew Skelly Ferriter
Michiel Mary Van Oort
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003251303A1 publication Critical patent/AU2003251303A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003251303A 2002-05-21 2003-05-20 Pharmaceutical products and methods of manufacture Abandoned AU2003251303A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38223302P 2002-05-21 2002-05-21
US60/382,233 2002-05-21
PCT/US2003/015690 WO2003099290A1 (en) 2002-05-21 2003-05-20 Pharmaceutical products and methods of manufacture

Publications (1)

Publication Number Publication Date
AU2003251303A1 true AU2003251303A1 (en) 2003-12-12

Family

ID=29584380

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003251303A Abandoned AU2003251303A1 (en) 2002-05-21 2003-05-20 Pharmaceutical products and methods of manufacture

Country Status (2)

Country Link
AU (1) AU2003251303A1 (en)
WO (1) WO2003099290A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060272A1 (en) 2004-05-24 2006-05-22 Glaxo Group Ltd (2R, 3R, 4S, 5R, 2'R, 3'R, 4'S, 5'S) -2.2 '- {TRANS-1,4-CYCLOHEXANODIYLBIS- [IMINO (2 - {[2- (1-METHYL- 1H-IMIDAZOL-4-IL) ETHYL] AMINO} -9H-PURIN-6,9-DIYL)]} BIS [5- (2-ETHYL-2H-TETRAZOLE-5-IL) TETRAHYDRO-3,4-FURANODIOL] AS AN A2A AGONIST
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
PT3130396T (en) 2009-03-27 2021-05-12 Bend Res Inc Spray-drying process
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
AU2013259872B2 (en) 2012-05-08 2018-06-28 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
JP6650933B2 (en) * 2014-10-31 2020-02-19 ベンド リサーチ， インコーポレイテッド Process for forming active drug domains dispersed in a matrix

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9005110D0 (en) * 1990-03-07 1990-05-02 Fisons Plc Inhalation device
DE19847969A1 (en) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Stable liquid formulation of formoterol in solution or suspension medium, used after dilution for treatment of asthma by inhalation

Also Published As

Publication number Publication date
WO2003099290A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
AU2003301024A1 (en) Inflatable products and methods of their formation and use
AU2003287625A1 (en) Materials and methods for the efficient production of acetate and other products
AU2003280324A1 (en) Pharmaceutical allergen product
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2002237816A1 (en) Point-of-sale activation and subsequent registration of products
AU2003201513A1 (en) Methods of producing silk polypeptides and products thereof
AU2003282558A1 (en) Nanopellets and method of making nanopellets
AU2003269444A1 (en) An improved pacifier and method of use thereof
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
AU2003237574A1 (en) Confectionery product and method of preparation
AU2003201987A1 (en) Microparticles and methods of making them
AU2003297612A1 (en) 2-substituted-3-propenamide derivatives and methods of using the same
AU2003251303A1 (en) Pharmaceutical products and methods of manufacture
AU2003282375A1 (en) Pharmaceutical compositions and process of production thereof
AU2002246950A1 (en) Hydrocapsules and method of preparation
AU2003294684A1 (en) Ketoprofen compositions and methods of making them
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2002324081A1 (en) Board product and method for the preparation of the same
AU2003295713A1 (en) Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions
AU2003240052A1 (en) Il-11 derivatives and therapeutic uses thereof
AU2003301457A1 (en) Bioweapon-detecting fibrous-network products and methods for making same
AU2003286392A1 (en) 1microarrays and production thereof
AU2003291882A1 (en) Pharmaceutical combinations and methods for the treatment of leukemia
AUPS337502A0 (en) Food product and method of manufacture
AU2003300694A1 (en) Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them